We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Essen BioScience Launches New Live Cell Imaging System

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Essen BioScience Inc. has announced the launch of its new live cell imaging system, IncuCyte ZOOM™, as well as an expanded line of novel CellPlayer™ reagents specifically developed by Essen for use on the platform.

The IncuCyte ZOOM™ is the 2nd generation live-cell imaging platform offered by Essen.

A unique aspect of the IncuCyte technology is that the system acquires images automatically from within the user’s cell culture incubator, enabling users to gather biological image data around-the-clock without removing the cells from their physiological environment.

The IncuCyte is also equipped with integrated software providing full quantification of the real-time biological processes under observation.

New features on the ZOOM include multi-fluorescent colors, support of a broader range of magnifications, enhanced phase contrast processing tools and more speed.

The new CellPlayer™ reagents include targeted fluorescent probes and fully validated GFP/RFP nuclear labeled stable cell lines.

These reagents are non-perturbing to cell health and superior to traditional organic dye labels for long term imaging assays.

Together, the IncuCyte Zoom and suite of CellPlayer™ reagents and assays provide a fully integrated solution for quantitative long term kinetic biology; an approach we call Live Content Imaging.

“We are very excited about the release of ZOOM and associated CellPlayer™ reagents”, says Kirk Schroeder, President of Essen BioScience.

Schroeder continued, “Drug discovery research is continuing to move to more advanced, mixed culture assay models in order to better predict in vivo biology. These new offerings make it easy to monitor multiple cell types with non-perturbing labels and a full kinetic read-out; a new dimension for in vitro cell biology.”